Bone and Immune Cell Interactions

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition

Volumn , Issue , 2013, Pages 1036-1042

  Boyce, Brendan F ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Bone cell interactions; Immune cell interactions; Immune responses; Lymphocytes; Nuclear factor kappa B (NF B); Osteoclast; Osteomyelitis; RANKL

Indexed keywords

EID: 84927910692     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118453926.ch124     Document Type: Chapter

References (57)

1. Rodan GA, Martin TJ. 1982. Role of osteoblasts in hormonal control of bone resorption-A hypothesis. Calcif Tissue Int 34 (3): 311.
2. Vallabhapurapu S, Karin M. 2009. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 27: 693-733.
3. Franzoso G, Carlson L, Xing L, Poljak L, Shores EW, Brown KD, Leonardi A, Tran T, Boyce BF, Siebenlist U. 1997. Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev 11 (24): 3482-96.
4. Iotsova V, Caamaño J, Loy J, Yang Y, Lewin A, Bravo R. 1997. Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med 3 (11): 1285-9.
5. Boyle WJ, Simonet WS, Lacey DL. 2003. Osteoclast differentiation and activation. Nature 423 (6937): 337-42.
6. Kollet O, Dar A, Lapidot T. 2007. The multiple roles of osteoclasts in host defense: Bone remodeling and hematopoietic stem cell mobilization. Annu Rev Immunol 25: 51-69.
7. Battiwalla M, Hematti P. 2009. Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy 11 (5): 503-15.
8. Ratajczak MZ, Zuba-Surma EK, Wojakowski W, Ratajczak J, Kucia M. 2008. Bone marrow-Home of versatile stem cells. Transfus Med Hemother 35 (3): 248-59.
9. Karsenty G, Wagner EF. 2002. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2 (4): 389-406.
10. Arai F, Miyamoto T, Ohneda O, Inada T, Sudo T, Brasel K, Miyata T, Anderson DM, Suda T. 1999. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med 190 (12): 1741-54.
11. Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-Hora M, Feng JQ, Bonewald LF, Kodama T, Wutz A, Wagner EF, Penninger JM, Takayanagi H. 2011. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med 17 (10): 1231-4.
12. Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O ' Brien CA. 2011. Matrix-embedded cells control osteoclast formation. Nat Med 17 (10): 1235-41.
13. Masuyama R, Stockmans I, Torrekens S, Van Looveren R, Maes C, Carmeliet P, Bouillon R, Carmeliet G. 2006. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest 116 (12): 3150-9.
14. Usui M, Xing L, Drissi H, Zuscik M, O ' Keefe R, Chen D, Boyce BF. Murine and chicken chondrocytes regulate osteoclastogenesis by producing RANKL in response to BMP2. J Bone Miner Res 23 (3): 314-25.
15. Henriksen K, Karsdal M, Delaisse JM, Engsig MT. 2003. RANKL and vascular endothelial growth factor (VEGF) induce osteoclast chemotaxis through an ERK1/2-dependent mechanism. J Biol Chem 278 (49): 48745-53.
16. Muto A, Mizoguchi T, Udagawa N, Ito S, Kawahara I, Abiko Y, Arai A, Harada S, Kobayashi Y, Nakamichi Y, Penninger JM, Noguchi T, Takahashi N. 2011. Lineagecommitted osteoclast precursors circulate in blood and settle down into bone. J Bone Miner Res 26 (12): 2978-90.
17. Takayanagi H. 2007. Osteoimmunology: Shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7 (4): 292-304.
18. Boyce BF, Xing L. 2008. Functions of RANKL/RANK/ OPG in bone modeling and remodeling. Arch Biochem Biophys 473 (2): 139-46.
19. Boyce BF, Yao Z, Xing L. 2010. Functions of nuclear factor kappaB in bone. Ann N Y Acad Sci 1192: 367-75.
20. Zhang Q, Badell IR, Schwarz EM, Boulukos KE, Yao Z, Boyce BF, Xing L. 2005. Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2. Arthritis Rheum 52 (9): 2708-18.
21. Yao Z, Xing L, Boyce BF. 2009. NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism. J Clin Invest 119 (10): 3024-34.
22. Okamoto K, Takayanagi H. 2011. Regulation of bone by the adaptive immune system in arthritis. Arthritis Res Ther 13 (3): 219.
23. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ, Takayanagi H. 2006. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203 (12): 2673-82.
24. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM. 1999. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402 (6759): 304-9.
25. Zaiss MM, Axmann R, Zwerina J, Polzer K, Gückel E, Skapenko A, Schulze-Koops H, Horwood N, Cope A, Schett G. 2007. Treg cells suppress osteoclast formation: A new link between the immune system and bone. Arthritis Rheum 56 (12): 4104-12.
26. Pacifici R. 2012. Role of T cells in ovariectomy induced bone loss-revisited. J Bone Miner Res 27 (2): 231-9.
27. Pacifici R. 2010. The immune system and bone. Arch Biochem Biophys 503 (1): 41-53.
28. Manolagas SC. 2010. From estrogen-centric to aging and oxidative stress: A revised perspective of the pathogenesis of osteoporosis. Endocr Rev 31 (3): 266-300.
29. Li H, Hong S, Qian J, Zheng Y, Yang J, Yi Q. 2010. Cross talk between the bone and immune systems: Osteoclasts function as antigen-presenting cells and activate CD4 + and CD8 + T cells. Blood 116 (2): 210-7.
30. Grassi F, Manferdini C, Cattini L, Piacentini A, Gabusi E, Facchini A, Lisignoli G. 2011. T cell suppression by osteoclasts in vitro. J Cell Physiol 226 (4): 982-90.
31. Townsend MJ, Monroe JG, Chan AC. 2010. B-cell targeted therapies in human autoimmune diseases: An updated perspective. Immunol Rev 237 (1): 264-83.
32. Manabe N, Kawaguchi H, Chikuda H, Miyaura C, Inada M, Nagai R, Nabeshima Y, Nakamura K, Sinclair AM, Scheuermann RH, Kuro-o M. 2001. Connection between B lymphocyte and osteoclast differentiation pathways. J Immunol 167 (5): 2625-31.
33. Schett G, David JP. 2010. The multiple faces of autoimmune-mediated bone loss. Nat Rev Endocrinol 6 (12): 698-706.
34. Tilg H, Moschen AR, Kaser A, Pines A, Dotan I. 2008. Gut, inflammation and osteoporosis: Basic and clinical concepts. Gut 57 (5): 684-94.
35. Hanada R, Leibbrandt A, Hanada T, Kitaoka S, Furuyashiki T, Fujihara H, Trichereau J, Paolino M, Qadri F, Plehm R, Klaere S, Komnenovic V, Mimata H, Yoshimatsu H, Takahashi N, von Haeseler A, Bader M, Kilic SS, Ueta Y, PiflC, Narumiya S, Penninger JM. 2009. Central control of fever and female body temperature by RANKL/RANK. Nature 462 (7272): 505-9.
36. Lieb W, Gona P, Larson MG, Massaro JM, Lipinska I, Keaney JF Jr, Rong J, Corey D, Hoffmann U, Fox CS, Vasan RS, Benjamin EJ, O ' Donnell CJ, Kathiresan S. 2010. Biomarkers of the osteoprotegerin pathway: Clinical correlates, subclinical disease, incident cardiovascular disease, and mortality. Arterioscler Thromb Vasc Biol 30 (9): 1849-54.
37. Jones DH, Nakashima T, Sanchez OH, Kozieradzki I, Komarova SV, Sarosi I, Morony S, Rubin E, Sarao R, Hojilla CV, Komnenovic V, Kong YY, Schreiber M, Dixon SJ, Sims SM, Khokha R, Wada T, Penninger JM. 2006. Regulation of cancer cell migration and bone metastasis by RANKL. Nature 440 (7084): 692-6.
38. Chen G, Sircar K, Aprikian A, Potti A, Goltzman D, Rabbani SA. 2006. Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation. Cancer 107 (2): 289-98.
39. Taylor R, Kashima TG, Knowles H, Gibbons CL, Whitwell D, Athanasou NA. 2011. Osteoclast formation and function in pigmented villonodular synovitis. J Pathol 225 (1): 151-6.
40. Shishido-Hara Y, Kurata A, Fujiwara M, Itoh H, Imoto S, Kamma H. 2010. Two cases of breast carcinoma with osteoclastic giant cells: Are the osteoclastic giant cells pro-tumoural differentiation of macrophages? Diagn Pathol 5: 55.
41. Koga T, Inui M, Inoue K, Kim S, Suematsu A, Kobayashi E, Iwata T, Ohnishi H, Matozaki T, Kodama T, Taniguchi T, Takayanagi H, Takai T. 2004. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428 (6984): 758-63.
42. Barrow AD, Raynal N, Andersen TL, Slatter DA, Bihan D, Pugh N, Cella M, Kim T, Rho J, Negishi-Koga T, Delaisse JM, Takayanagi H, Lorenzo J, Colonna M, Farndale RW, Choi Y, Trowsdale J. 2011. OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice. J Clin Invest 121 (9): 3505-16.
43. Shinohara M, Koga T, Okamoto K, Sakaguchi S, Arai K, Yasuda H, Takai T, Kodama T, Morio T, Geha RS, Kitamura D, Kurosaki T, Ellmeier W, Takayanagi H. 2008. Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals. Cell 132 (5): 794-806.
44. Sato K, Suematsu A, Nakashima T, Takemoto-Kimura S, Aoki K, Morishita Y, Asahara H, Ohya K, Yamaguchi A, Takai T, Kodama T, Chatila TA, Bito H, Takayanagi H. 2006. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway. Nat Med 12 (12): 1410-6.
45. Wang ZQ, Ovitt C, Grigoriadis AE, Möhle-Steinlein U, Rüther U, Wagner EF. 1992. Bone and haematopoietic defects in mice lacking c-fos. Nature 360 (6406): 741-5.
46. Tsukayama DT. 1999. Pathophysiology of posttraumatic osteomyelitis. Clin Orthop 360: 22-9.
47. Bar-Shavit Z. 2008. Taking a toll on the bones: Regulation of bone metabolism by innate immune regulators. Autoimmunity 41 (3): 195-203.
48. Varoga D, Wruck CJ, Tohidnezhad M, Brandenburg L, Paulsen F, Mentlein R, Seekamp A, Besch L, Pufe T. 2009. Osteoblasts participate in the innate immunity of the bone by producing human beta defensin-3. Histochem Cell Biol 131 (2): 207-18.
49. Jevon M, Guo C, Ma B, Mordan N, Nair SP, Harris M, Henderson B, Bentley G, Meghji S. 1999. Mechanisms of internalization of Staphylococcus aureus by cultured human osteoblasts. Infect Immun 67 (5): 2677-81.
50. Glass GE, Chan JK, Freidin A, Feldmann M, Horwood NJ, Nanchahal J. 2011. TNF-alpha promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells. Proc Natl Acad Sci U S A 108 (4): 1585-90.
51. Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, Korb A, Smolen J, Hoffmann M, Scheinecker C, van der Heide D, Landewe R, Lacey D, Richards WG, Schett G. 2007. Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13 (2): 156-63.
52. Zhao C, Irie N, Takada Y, Shimoda K, Miyamoto T, Nishiwaki T, Suda T, Matsuo K. 2006. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab 4 (2): 111-21.
53. Kwan Tat S, Pelletier JP, Amiable N, Boileau C, Lajeunesse D, Duval N, Martel-Pelletier J. 2008. Activation of the receptor EphB4 by its specific ligand ephrin B2 in human osteoarthritic subchondral bone osteoblasts. Arthritis Rheum 58 (12): 3820-30.
54. Suzuki K, Kumanogoh A, Kikutani H. 2008. Semaphorins and their receptors in immune cell interactions. Nat Immunol 9 (1): 17-23.
55. Takamatsu H, Takegahara N, Nakagawa Y, Tomura M, Taniguchi M, Friedel RH, Rayburn H, Tessier-Lavigne M, Yoshida Y, Okuno T, Mizui M, Kang S, Nojima S, Tsujimura T, Nakatsuji Y, Katayama I, Toyofuku T, Kikutani H, Kumanogoh A. 2010. Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II. Nat Immunol 11 (7): 594-600.
56. Pennisi A, Ling W, Li X, Khan S, Shaughnessy JD Jr, Barlogie B, Yaccoby S. 2009. The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth. Blood 114 (9): 1803-12.
57. Lee SH, Rho J, Jeong D, Sul JY, Kim T, Kim N, Kang JS, Miyamoto T, Suda T, Lee SK, Pignolo RJ, Koczon-Jaremko B, Lorenzo J, Choi Y. 2006. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med 12 (12): 1403-9.